+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
BETA
₹1,672.30 -5.4 (-0.32%)
40.44% Fall from 52W High

14 Oct, 2026 11:31 AM (IST)

Beta Drugs live price: ₹1,672.30. It opened at ₹1,686 vs previous close ₹1,678; intraday high/low: ₹1,719/₹1,625. The 50 & 200 DMA stand at ₹2,087.70/₹1,872.10.

Beta Drugs Performance

  • Today's Low
  • ₹1,625
  • Today's High
  • ₹1,719
  • 52 Week Low
  • ₹990
  • 52 Week High
  • ₹2,808
  • Open Price₹1,686
  • Previous Close₹1,678
  • Volume37,905
  • 50 DMA₹2,087.70
  • 100 DMA₹2,015.50
  • 200 DMA₹1,872.10

Beta Drugs Chart

Investment Returns

  • Over 1 Month -21.06%
  • Over 3 Month -28.77%
  • Over 6 Month + 19.39%
  • Over 1 Year -2.77%

Smart Investing Starts Here Start SIP with Beta Drugs for Steady Growth!

Invest Now

Beta Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 40.7
  • PEG Ratio
  • -
  • Market Cap Cr
  • 1,854
  • P/B Ratio
  • 7.1
  • Average True Range
  • 118.5
  • EPS
  • 41.1
  • Dividend Yield
  • 0
  • MACD Signal
  • -93.4
  • RSI
  • 25.63
  • MFI
  • 20.91

Latest Stock News Updates

Beta Drugs up 3% on approval to migrate shares from SME to mainboard

The buying on the counter came after the company received the approval for listing its equity shares on the Capital Market Segment (Main Board) from SME Emerge platform (NSE)

Bonus shares: THESE three stocks to trade ex-bonus next week (Beta Drugs, Dhanalaxmi Roto Spinners, and KBC Global)

Bonus shares: Here are three stocks to trade ex-bonus next week ' These include Beta Drugs, Dhanalaxmi Roto Spinners, and KBC Global)

Healthquad Fund II Invests Rs 117 Crore In Beta Drugs For Minority Stake

The company will use the newly raised funds to accelerate its growth and aspires to be among the top five oncology companies in India.

Beta Drugs Financials

Beta Drugs Technicals

EMA & SMA

Current Price
₹1,672.30
-5.4 (-0.32%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹2,003.50
  • 50 Day
  • ₹2,087.70
  • 100 Day
  • ₹2,015.50
  • 200 Day
  • ₹1,872.10

Resistance and Support

1672.07 Pivot Speed
  • R3 2,004.10
  • R2 1,931.80
  • R1 1,804.70
  • S1 1,605.30
  • S2 1,533.00
  • S3 1,405.90

Beta Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-09-03 Other business matters
2026-07-20 Quarterly Results To consider and approve the financial results for the period ended Jun 30, 2026
2026-05-14 Audited Results
2026-02-14 Quarterly Results
2026-01-09 Others To consider 1. Approve the Employee Stock Option Plan (ESOP). 2. Acquisition of equity shares of a target company from certain shareholders of the target company. 3. Other business matters.
Date Purpose Remarks
2025-03-26 Bonus Bonus issue of equity shares in the ratio of 1:20 of Rs. 10/-.

Beta Drugs Shareholding Pattern

59.1%
33.65%
6.23%
1.02%

About Beta Drugs

Beta Drugs is an India-based pharmaceutical company specializing in the development, manufacturing, and marketing of anti-cancer (oncology) medications and formulations View More
  • NSE Symbol
  • BETA
  • BSE Symbol
  • 531481
  • ISIN
  • INE351Y01019

Similar Stocks to Beta Drugs

Beta Drugs FAQs

Beta Drugs share price is ₹1,672 As on 14 October, 2026 | 11:17

The Market Cap of Beta Drugs is ₹1853.9 Cr As on 14 October, 2026 | 11:17

The P/E ratio of Beta Drugs is 40.7 As on 14 October, 2026 | 11:17

The PB ratio of Beta Drugs is 7.1 As on 14 October, 2026 | 11:17

The 52 week High & Low of Beta Drugs is ₹2807.9/₹990.1 respectively As on 14 October, 2026 | 11:17

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23